Virus therapy trial for breast cancer pulled before starting
NCT ID NCT07150767
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 31 times
Summary
This study was designed to test the safety and effectiveness of a new virus-based treatment (BioTTT001) combined with standard pre-surgery therapy for women with locally advanced breast cancer. The trial was withdrawn before enrolling any participants, so no results are available. It would have involved injecting the virus directly into tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED BREAST CANCER (LABC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Second People's Hospital of Shandong Province
Jinan, Shandong, 250022, China
Conditions
Explore the condition pages connected to this study.